The Moderna earnings call discussed financial results, cost savings, COVID vaccine sales, clinical programs, and pipeline updates. The company aims to drive sales, cost efficiency, and vaccine approvals. Revenue sources, market share dynamics, and future growth opportunities were also highlighted.